Simulations Plus Releases ADMET Predictor Version 7.2
Enhances synergy between predicted properties and GastroPlus™ Version 9.0 modeling capabilities
Simulations Plus Releases GastroPlus Version 9.0
Important new features expand market for flagship software product
Simulations Plus Augments Marketing and Sales Organization with Addition of Seasoned Scientist
Dr. Michael Lawless to transition to Marketing and Sales Team.
Dr. Vijay Gombar joins the Company as leader of the Cheminformatics Studies Team.
Simulations Plus Reports Second Quarter FY2015 Financial Results
Final report of second quarter financial results
Cognigen quarterly profits rise
Consolidated net revenues up 48.4%; second quarter net income increases 19.8%
Simulations Plus Reports First Quarter FY2015 Financial Results
Final report of first quarter financial results after Cognigen merger; net revenues up 54%; gross profit increased 41%
Simulations Plus Sets Date for 1st Quarter 2015 Earnings Release and Conference Call
Conference Call to be on Wednesday, January 14, at 4:15 PM ET
Simulations Plus Reports First Quarter FY2015 Preliminary Revenues
Preliminary revenues increase 50% to first quarter record $3.96 million
Simulations Plus Reports FY2014 and Fourth Quarter FY2014 Financial Results
Full Fiscal Year Pharmaceutical Software and Services up 13.8%, Fourth Quarter Revenues up 27.4%
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2014 Earnings Release and Conference Call
Conference Call to be on Tuesday, November 25, 2014, at 4:15 PM EST
Simulations Plus Announces Changes in Board of Directors
Dr. John Paglia, Ph.D., CFA, CPA to Replace Mr. Harold Wayne Rosenberger Retiring after 7 Years on Board
Simulations Plus Announces Quarterly Cash Dividend of $0.05 Per Share
Cash dividend yield of 3.3% to be distributed in November